Advertisement
Advertisement

ACRV

ACRV logo

Acrivon Therapeutics, Inc. Common Stock

1.98
USD
Sponsored
-0.05
-2.46%
May 08, 16:00 UTC -4
Closed
exchange

After-Market

1.99

+0.01
+0.56%

Acrivon Therapeutics, Inc. Common Stock Profile

About

Acrivon Therapeutics Inc. is a clinical stage biopharmaceutical company developing precision oncology medicines which matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing Acrivon's proprietary proteomics-based patient responder identification platform, Acrivon Predictive Precision Proteomics. The company's lead candidate includes ACR-368. Acrivon Therapeutics Inc. is based in WATERTOWN, Mass.

Info & Links

CEO

Peter Blume-Jensen

Headquarters

480 ARSENAL WAY, SUITE 100
WATERTOWN, MA 02472, UNITED STATES

Industry

Medical Drugs

Sector

Medical

Website

www.acrivon.com

Auditor

PricewaterhouseCoopers LLP

Share holders

6

Employees

76

Acrivon Therapeutics, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

85.22M

Enterprise Value

43.72M

Enterprise Value/EBITDA(ttm)

-0.53

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

0.43

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-57.23%

Return on Invested Capital(ttm)

-58.01%

Return on Assets(ttm)

-51.09%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-83.19M

Net Income Available to Common(ttm)

-77.91M

Diluted EPS(ttm)

-2.02

Share Statistics

Beta (5Y Monthly)

1.72

52-Week Change

67.80%

S&P 500 52-Week Change

26.60%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

38.74M

Dividend Yield

0.00%

Float4

34.13M

% Held by Insiders

11.90%

% Held by Institutions

71.62%

Balance Sheet

Total Cash(mrq)

118.58M

Total Cash Per Share(mrq)

3.06

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

7.69%

Quick Ratio(mrq)

7.69%

Book Value Per Share(mrq)

3.56

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.65

Free Cash Flow(ytd)

-65.33M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement